The advent of automation in the ultrasound in diagnosing sarcopenia, osteoporosis, and middle-ear effusion diseases market has highly benefited the healthcare industry. The workflow of ultrasound procedure, especially a newer one offering three-dimensional technology, has been reduced considerably owing to artificial intelligence. Artificial intelligence algorithms are being increasingly integrated into the backend of the ultrasound scanning systems to fasten the workflow and enhance visual mapping. One of the longest tasks in ultrasound is picking out the ideal image for a proper assessment, which was initially done manually and required a significant amount of time. However, artificial intelligence has changed and impacted that tremendously. In the earlier days, echo study required sonographers to flip through several images to pick out the images that would help them in diagnosis the disease in the most precise manner. Artificial intelligence has completely removed the extra effort by allowing the doctors to depend on an algorithm to pick out the exact images that might help them in carefully assessing the diseased part of the organs or tissues. This allows doctors in saving critical time, which they can rather spend with more patients and in a contribution to substantial scientific research.

Moreover, healthcare companies are making the process even easier with the integration of artificial intelligence empowered voice recognition technology that allows a hands-free operation to the doctors. Clinicians can carefully scan the patient without making use of their hands in controlling the system. These developments have immensely helped the Ultrasound in Diagnosing Sarcopenia, Osteoporosis and Middle-ear Effusion Diseases Market and will be responsible for its growth in the upcoming years. During the forecast period of 2019-2025, the market will grow at a CAGR of 3.6% and earned a revenue of $751m in 2018.

Growth Drivers of The Market

·         The Rise of Sarcopenia In Aging Population

Owing to advancement in healthcare services considerably improved across the globe, the world is currently witnessing a noticeable increase in the aging population. There has been observed a substantial rise in world’s older population owing to other factors as well which includes an increase in pension programs, governmental efforts to improve means of living a lifestyle despite musculoskeletal issues, eradication of several diseases such as smallpox, polio, and others. According to the United States of America’s National Institutes of Health, the global population of people aged 80 or above will triple by the end of 2050 and reach an approximate 446.6 million from current 126.5 million. Despite these statistics, it can be established that being older does not necessarily equate to being healthier. The geriatric population suffers from several diseases that get worse with age. Sarcopenia, defined as a syndrome that is characterized by a steady loss of muscle mass and subsequent loss of strength, is becoming prominent in the aging population with every passing day. In 2016 conference titled ‘World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases’ that took place in Malaga, Spain, it was predicted that the percentage of aging population affected by Sarcopenia in the continent of Europe would increase from 20% to 63% by the end of 2045. Sarcopenia can pose several challenges for people, which includes a decline in mobility and development of propensity to avoid physical activity. Some of the leading causes of this disease include living a sedentary life at a young age, which leads to weakening of muscle mass. Moreover, poor nutrition is also a growing cause for the increase of Sarcopenia amongst the aging population. These factors have provided impetus to the global ultrasound in sarcopenia disease market as a proper diagnosis of this disease can only be performed with an efficient and accurate ultrasound.

·         Increasing Incidences of Osteoporosis

Contrary to popular belief, osteoporosis can affect people of all ages, and there has been observed an increase in the younger population. Osteoporosis is a musculoskeletal disease which, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, has already impacted around 53 million people in the U.S. Moreover, alarming statistics published by the International Osteoporosis Foundation state that around one osteoporotic fracture occurs once in every three seconds. Though osteoporosis symptoms are directly proportional to the increase in age, young people are regularly diagnosed by it in recent times, albeit rarer than older people. A growing number of patients worldwide on account of their osteoporosis symptoms directly as a result of sedentary lifestyle and genetics are obtaining ultrasounds to get an accurate diagnosis. With the increase of age, the bone strength becomes considerably weaker, which leads to an aggravation of osteoporosis, thereby helping the ultrasound in osteoporosis disease market in attaining considerable growth.

·         Unattended Ear Health and Subsequent Middle-Ear Effusion Diseases

Human beings are highly negligent toward their ear health. Ears are responsible for not only hearing but for retaining a balance in our bodies as well. According to the National Institute on Deafness and Other Communication Disorders, approximately 37.5 million adults in the U.S. have trouble hearing. Moreover, approximately 3 out of every 1000 children are born with a hearing defect most likely to hearing parents. One of the common and alarming ear defects include middle ear effusion which consists of a fluid build-up behind the eardrum, which only occurs in children. This is more likely to happen during or after a cold or an ear infection when the ear canal produces more fluid than necessary. One of the most common ways to diagnose middle ear effusion is ultrasound, which is beneficial for kids owing to its non-invasive method of diagnosis. Since ultrasound makes use of high-frequency waves, the acoustic characteristics of the ear canal are made prominent after performing it on a child’s ear. This is a relatively newer technology that the doctors are slowly adopting for examining the mastoid to detect middle ear effusion. Increasing acceptance from both patients, their guardians, as well as the doctors, have positively impacted the ultrasound for middle ear effusion market.

Growing Trends Observed in the Ultrasound in Diagnosing Sarcopenia, Osteoporosis, and Middle-ear Effusion Diseases Market

Ø  Real-Time 3D

In a first, real-time three-dimensional technology has entered the ultrasound market. It provides a finer view of anatomical structures by making use of real-time imaging, thus providing a better understanding of underlying health issues in the organs. In physiotherapy, for example, real-time ultrasounds can be used to show how the muscles work, something that was not possible before with 2D ultrasound. This helps patients in analyzing the kind of movement patients should be making for supporting their body structure, which is essential in sarcopenia and osteoporosis. One of the prime 3D ultrasound technology prototypes was released in 2018 by GE Healthcare called Imaging Elevated. It provides a comparatively better workflow and imaging quality, especially for cardiac systems.

Ø  Point-of-Care Ultrasound

Point of care ultrasound or POCUS has seen a tremendous increase in application in the past few years. These are pocket-sized ultrasound systems that allow a quick look inside a patient’s anatomy. These are mostly being solicited for acquiring information pertaining to the body’s necessity or requirement for a higher level of diagnosis. In the current scenario, imaging technology companies are releasing their point of care ultrasound systems that come embedded with a kiosk system and touchscreen for ease of accessibility. One of the examples is the portable SonoSite X-Porte released by Fujifilm SonoSite Inc., which offers an evident display with minimal adjustments required during the viewing of diseases.

Ultrasound in Diagnosing Sarcopenia, Osteoporosis, and Middle-ear Effusion Diseases Market: Major Players Operating in the Market

Key market players of the ultrasound in diagnosing sarcopenia, osteoporosis, and middle-ear effusion diseases market include Mayo Foundation for Medical Education and Research, RadNet, Bupa, Cleveland Clinic, Life Healthcare Group, Johns Hopkins Medicine, Lakeshore Diagnostic Ultrasound Company, Quest Diagnostics, Laboratory Corporation of America Holdings, and Sonic Healthcare Limited.

Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

To request for a quote, provide your details in the below link:

https://industryarc.com/reports/request-quote?id=19180

Media Contact:

Mr. Venkat Reddy

Sales Manager          

Email: [email protected]

Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.